ArrePath Appoints Kevin Krause as CEO to Lead Growth
Key Highlights Kevin Krause named as President and CEO of ArrePath. Brings 25+ years of biotech experience, including…
Browsing Tag
AN2 Therapeutics Inc.
1 post